A new species of Ribautiella (Myriapoda, Symphyla, Scolopendrellidae) from an Amazonian black-water inundation forest and notes on its natural history and ecology

Ribautiella amazonica is described from a black-water inundation forest near Manaus, Brazil. The genus is recorded for the first time for the Americas. R. amazonica was predominantly collected from the forest soil, mainly between 7 and 14 cm depth and is considered euedaphic. Data indicate, that advanced immature stages and adults withstand forest-inundation of 5 - 6 months duration in the soil and reproduce in the early part of the emersion period

Sedimentological studies of the "Ilha de Marchantaria" in the Solimões/Amazon River near Manaus

Sedimentological studies on the Ilha de Marchantaria an island in the Amazon river near Manaus reveal the existence of four different structural main units. A: Sandy channel bars consisting of giant ripples constitute deposits for the formation of islands or newly formed areas of the Varzea. B: Gradual accumulation on the channel bars leads to the formation of point bar ridges which consist chiefly of small-scale ripples. C: Between point bar ridges of different ages there exist swales. During rising water level the river water flows from the downward side into the swales where finegrained sediments are deposited. D: Permanent lakes are formed mainly in the centre of the islands. During low water periods the lakes may be cut of from the river. During high water periods when the whole island is flooded by the river, additional sedimentation takes place especially in the upstream area of the island. There is however, extensive erosion of the banks on the upstream side of the island. By erosion of the upstream end and sedimentation processes on the downstream end the island moves slowly downstream

Analysis of FDS’s Risk Assessment Methodology at Pharmaceutical Manufacturing Site

This research describes how the FDA has incorporated risk analysis methodology into its inspection of pharmaceutical manufacturers in the time period between 2004-2008. It analyzes the violations specified in FDA warning letters that are issued after site inspections of pharmaceutical facilities. The outcome of this analysis is to evaluate the FDA’s performance to determine whether it has improved the overall inspection process and increased its quality assuranc

The Next Generation of Mobile Computing for Hospitals

Mobile computing in the broadest sense is when multiple communications devices work together within an environment, unhampered by equipment limitations, distance, or interference. As computer and networking devices are put into smaller and smaller envelopes, their workplace usefulness increases. These mobile devices offer the potential of increasing the quality of healthcare services by making better use of hospital resources, including improved communications among medical and support staff, and increased patient monitoring. This paper depicts several hospital scenarios in order to conceptualize the planning and design of future mobile networks, taking into consideration patient care, management thinking, and technical issues

McNeil, Ft. Washington: FDA Case Study

This research analyzes the Food and Drug Administration’s (FDA) quality systems methodology through a detailed 12-year case study of McNeil Consumer Healthcare and its Ft. Washington, Pennsylvania manufacturing facility. This in-depth review, from 2000 to 2011, includes plant inspections reports, out-of-compliance findings, warning letters and a plant closure injunction. It then contrasts the specific findings of the McNeil case study with an analysis of overall FDA performance within the same sector of Finished Bio-Pharmaceuticals (BP). In addition, this case study pays particular attention to the role played by the FDA’s risk methodology in enhancing the overall inspection process and increasing its quality assurance

A Risk Modeling Framework for the Pharmaceutical Industry

This conceptual paper seeks to advance a theoretical discussion on risk modeling and how it is used within the context of business process modeling. It discusses developments in risk modeling and then shows how they have been applied to the USA pharmaceutical industry. The pharmaceutical industry is a particularly interesting example in that it is bound on one side by stringent USA government mandates, and on the other by a risk adverse consumer population. A third aspect, the expanding cost structure of drug production and compliance, adds to the complexity of the problem. The discussion of risk in this paper applies mainly to regulated industries, and may be less applicable to more unregulated industry sectors. The important lesson for researchers is that a risk framework can play a significant part in business process modeling. The format for this paradigm may very well resemble a process repository, similar to those found in knowledge management systems

Mobile Computing for Hospitals: Transition Problems

Mobile communication devices have an untapped potential to increase the quality of healthcare services. These devices can become the backbone for a new level of hospital service. This would include improved communications among medical and support staff and increased patient monitoring using a whole new generation of RFlDs. Yet, problems come with the introduction of new technology, some anticipated, some not. This paper develops several hospital scenarios depicting possible problem areas in the conceptualizing, planning and design of future mobile networks

Illustrated key for Neotropical Myriapoda (Arthropoda)

An illustrated key is given in Portuguese and German for the orders of neotropical Myriapoda (Arthropoda)

McNeil Healthcare, Puerto Rico: FDA Case Study

The McNeil case study examines the FDA’s quality assurance methodology through a detailed 12-year review of McNeil Consumer Healthcare, focusing on one of its major manufacturing facilities. It includes summaries from plant inspection reports, out-of-compliance findings, and warning letters for this period between 2000 and 2011. The results of this case study are then compared with a broader review of the FDA’s performance within the same sector of Finished Bio-Pharmaceuticals (BP) over a similar period. This analysis provides a perspective on how the FDA incorporates its risk methodology in the overall inspection process and in particular in its quality systems practices